Published in Allergy on February 01, 2006
Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev (2010) 2.44
Targeting skin dendritic cells to improve intradermal vaccination. Curr Top Microbiol Immunol (2012) 1.11
Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov (2009) 1.10
Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells. J Clin Invest (2012) 1.09
Langerhans cells and their role in oral mucosal diseases. N Am J Med Sci (2013) 0.90
Human skin and oral mucosal dendritic cells as 'good guys' and 'bad guys' in allergic immune responses. Clin Exp Immunol (2010) 0.87
Immune cells of the human peripheral taste system: dominant dendritic cells and CD4 T cells. Brain Behav Immun (2009) 0.86
The role of FcεRI expressed in dendritic cells and monocytes. Cell Mol Life Sci (2015) 0.85
Characterization of the human immune cell network at the gingival barrier. Mucosal Immunol (2016) 0.80
Human cytomegalovirus tropism for mucosal myeloid dendritic cells. Rev Med Virol (2014) 0.80
Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Derived Langerhans-Type Dendritic Cells. J Virol (2015) 0.78
Mechanisms of peptide immunotherapy in allergic airways disease. Ann Am Thorac Soc (2014) 0.78
Towards a cure for food allergy. Curr Opin Immunol (2008) 0.78
Current immunological approaches for management of allergic rhinitis and bronchial asthma. Inflamm Res (2009) 0.77
Modulation of dendritic cell innate and adaptive immune functions by oral and sublingual immunotherapy. Clin Immunol (2014) 0.77
An increase of CD83+ dendritic cells ex vivo correlates with increased regulatory T cells in patients with active eosinophilic granulomatosis and polyangiitis. BMC Immunol (2014) 0.75
Activation of Langerhans-Type Dendritic Cells Alters Human Cytomegalovirus Infection and Reactivation in a Stimulus-Dependent Manner. Front Microbiol (2016) 0.75
Dendritic Cell Subsets in Oral Mucosa of Allergic and Healthy Subjects. PLoS One (2016) 0.75
IgE-mediated allergen gene vaccine platform targeting human antigen-presenting cells through the high-affinity IgE receptor. J Allergy Clin Immunol (2009) 0.75
Endonasal phototherapy significantly alleviates symptoms of allergic rhinitis, but has a limited impact on the nasal mucosal immune cells. Eur Arch Otorhinolaryngol (2010) 0.75
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol (2004) 3.97
A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res (1999) 3.19
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med (1997) 2.29
Fetal cleft lip and palate: sonographic diagnosis, chromosomal abnormalities, associated anomalies and postnatal outcome in 70 fetuses. Ultrasound Obstet Gynecol (2001) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br J Dermatol (2005) 1.54
Early markers for protective mechanisms during rush venom immunotherapy. Allergy (2010) 1.50
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol (2012) 1.49
Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol (2001) 1.45
Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients. Allergy (2003) 1.44
[Atopic dermatitis. Version (17 July 2002 - modified final version)]. J Dtsch Dermatol Ges (2003) 1.39
Leprosy type 1 reaction as the first manifestation of borderline lepromatous leprosy in a young native German. Br J Dermatol (1997) 1.39
Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy (2007) 1.39
New treatment modalities for granuloma faciale. Br J Dermatol (2003) 1.31
Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol (1996) 1.31
Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection. J Infect Dis (1997) 1.23
Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect Immun (1996) 1.23
Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol (2006) 1.22
Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy (2013) 1.21
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy (2008) 1.20
Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature. J Eur Acad Dermatol Venereol (2011) 1.18
Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy (2008) 1.14
The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes. J Clin Invest (2000) 1.10
Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA. Br J Dermatol (2005) 1.10
CD1 expression is not affected by human peptide transporter deficiency. Hum Immunol (1994) 1.07
4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man. Int J Clin Pharmacol Ther (2009) 1.05
Immunological mechanisms of sublingual allergen-specific immunotherapy. Allergy (2011) 1.04
Sporotrichoid phaeohyphomycosis due to Alternaria infectoria. Br J Dermatol (2001) 1.04
Formation of target-specific neuronal projections in organotypic slice cultures from rat visual cortex. Nature (1990) 1.01
Analysis of the high affinity IgE receptor genes reveals epistatic effects of FCER1A variants on eczema risk. Allergy (2009) 1.01
Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adults. Clin Exp Allergy (2005) 1.01
The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets. Br J Dermatol (2007) 0.99
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy (2008) 0.99
Formation of specific afferent connections in organotypic slice cultures from rat visual cortex cocultured with lateral geniculate nucleus. J Neurosci (1992) 0.97
Human epidermal Langerhans cells internalize by receptor-mediated endocytosis T6 (CD1 "NA1/34") surface antigen. Birbeck granules are involved in the intracellular traffic of the T6 antigen. J Invest Dermatol (1987) 0.97
Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Allergy (2007) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy (2011) 0.95
Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol (2008) 0.95
Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J Immunol (2001) 0.95
Tissue expansion using osmotically active hydrogel systems for direct closure of the donor defect of the radial forearm flap. Plast Reconstr Surg (2001) 0.95
Evidence for a role of type I interferons in the pathogenesis of dermatomyositis. Br J Dermatol (2005) 0.94
Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, Fc epsilon RI. J Immunol (1995) 0.94
Generation of dendritic cell-based vaccines for cancer therapy. Br J Cancer (2002) 0.94
New reasons for histopathological nail-clipping examination in the diagnosis of onychomycosis. J Eur Acad Dermatol Venereol (2010) 0.92
Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment. Br J Dermatol (2004) 0.92
On treating male homosexuals. Arch Gen Psychiatry (1967) 0.92
Association of single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities. Allergy (2011) 0.92
Atopic dermatitis: pathogenetic mechanisms. Clin Exp Dermatol (2000) 0.92
Validation of a novel semi-automated method for three-dimensional surface rendering of condyles using cone beam computed tomography data. Int J Oral Maxillofac Surg (2013) 0.91
In search for predictive factors for atopy in human cord blood. Allergy (2005) 0.91
Antigen-presenting cells in allergy. J Allergy Clin Immunol (2001) 0.90
Atopic dermatitis: from the genes to skin lesions. Allergy (2000) 0.90
Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy (2013) 0.90
5-Lipoxygenase expression in Langerhans cells of normal human epidermis. Proc Natl Acad Sci U S A (1998) 0.90
The pathophysiology of atopic eczema. Clin Exp Dermatol (2006) 0.90
Human β-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. J Cell Physiol (2012) 0.89
Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg (2008) 0.89
Proactive therapy of atopic dermatitis--an emerging concept. Allergy (2008) 0.89
Membrane and soluble Fc gamma RII/III modulate the antigen-presenting capacity of murine dendritic epidermal Langerhans cells for IgG-complexed antigens. J Immunol (1995) 0.89
HLA-G: expression in human keratinocytes in vitro and in human skin in vivo. Eur J Immunol (1994) 0.89
Atopic eczema, Langerhans cells and allergy. Int Arch Allergy Appl Immunol (1991) 0.89
Clinical and biological effects of balneotherapy with selenium-rich spa water in patients with psoriasis vulgaris. Br J Dermatol (1995) 0.89
In situ expression of the costimulatory molecules CD80 and CD86 on langerhans cells and inflammatory dendritic epidermal cells (IDEC) in atopic dermatitis. Arch Dermatol Res (2001) 0.88
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial. Hum Gene Ther (2001) 0.88
Davos declaration: allergy as a global problem. Allergy (2012) 0.88
Human skin and oral mucosal dendritic cells as 'good guys' and 'bad guys' in allergic immune responses. Clin Exp Immunol (2010) 0.87
Embolia cutis medicamentosa of the foot after sclerotherapy. Eur J Dermatol (1999) 0.87
Human periodontal ligament cells facilitate leukocyte recruitment and are influenced in their immunomodulatory function by Th17 cytokine release. Cell Immunol (2011) 0.86
Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol (2001) 0.86
The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy. Allergy (2012) 0.86
Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis. J Eur Acad Dermatol Venereol (2009) 0.86
Human epidermal Langerhans cells express only the 40-kilodalton Fc gamma receptor (FcRII). J Immunol (1990) 0.86
Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy (2004) 0.86
Endodontic and surgical treatment of a geminated maxillary incisor. Int Endod J (2003) 0.86
Consensus statement on the safety profile of topical calcineurin inhibitors. Dermatology (2005) 0.86
The central role of FcepsilonRI in allergy. Clin Exp Dermatol (2003) 0.86
IgE receptors. Curr Opin Immunol (2001) 0.86
Pathogenesis of atopic dermatitis. Clin Exp Allergy (2015) 0.86
Pyoderma gangrenosum: another cutaneous side-effect of sunitinib? Br J Dermatol (2008) 0.86
Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. Allergy (2006) 0.85
Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plast Reconstr Surg (2001) 0.85